U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020645
Company: BAUSCH
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
AMMONUL SODIUM BENZOATE; SODIUM PHENYLACETATE 10%;10% (5GM/50ML;5GM/50ML) SOLUTION;INTRAVENOUS Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/17/2005 ORIG-1 Approval Type 3 - New Dosage Form PRIORITY Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020645ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/020645s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/22/2020 SUPPL-12 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020645s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020645Orig1s012ltr.pdf
01/10/2017 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

08/07/2013 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

06/30/2011 SUPPL-8 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020645s008ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/22/2020 SUPPL-12 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020645s012lbl.pdf
06/30/2011 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf
02/17/2005 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf
Back to Top